How Long Does THC Stay in the Body? Detection Windows and Workplace Impairment

For employers running a workplace drug screening program, the question of how long THC stays in the body is more complicated than it sounds — and answering it correctly is the key to understanding why some drug tests detect cannabis use for days while others detect it for weeks. The short answer is that the active compound clears the body within hours to a few days, but inactive metabolites can be detected for weeks or months depending on the testing method. The longer answer, which is the one that actually matters for program design, sits in the difference between duration of impairment and duration of detection — and that gap is the central challenge in workplace marijuana testing.

This article covers the practical science behind THC detection windows, what acute impairment actually looks like in a worker, and why the mismatch between detection and impairment shapes every decision about testing methods, panels, and program design. A companion article in this series covers the underlying biology — what marijuana is and how THC affects the brain and body.

Active THC vs. inactive metabolites

When THC enters the body, the liver processes it in stages. According to peer-reviewed pharmacokinetic research published in PMC, the three key compounds in this process are:

1. Delta-9 THC (the parent compound) — the active, psychoactive molecule. Causes the high. Half-life in blood: roughly 1 to 2 days for infrequent users, but can extend to 5 to 13 days for chronic users because of how THC is stored in body tissues.
2. 11-hydroxy-THC — an intermediate metabolite produced as the liver processes delta-9 THC. Also psychoactive, but short-lived in the bloodstream.
3. THC-COOH (carboxy-THC) — the inactive final metabolite. Has no psychoactive effect. Cannot cause impairment. Stored in fat tissue and slowly released over days, weeks, or even months.

The critical point for workplace testing is that delta-9 THC and THC-COOH tell completely different stories about a worker's actual condition. Delta-9 THC indicates recent use and possible current impairment. THC-COOH indicates that cannabis was used at some point in the past — possibly hours ago, possibly weeks ago — with no information about current state.

This distinction is why peer-reviewed research published in PMC has stated, in the context of workplace testing, that a positive result on a metabolite-based test "does not document impairment, or even recent use, when impairment is likely the most important parameter being searched for by the drug testing procedure."

Why THC lingers in the body so long

THC is fat-soluble, not water-soluble. This is the underlying chemistry that explains why it stays in the body so much longer than most workplace-relevant substances. According to NIH-cited research, THC binds to fatty tissues throughout the body and is slowly released back into the bloodstream over time.

Body composition matters: a higher body fat percentage means longer THC retention. When a person exercises or burns fat, stored THC can temporarily re-enter the bloodstream, which is why detection times vary significantly between individuals. This fat-solubility is also why there is no straightforward way to predict how long someone will test positive after their last use — frequency, dose, body composition, metabolism, and hydration all change the answer.

Detection windows by testing method

Different testing matrices detect different compounds and produce dramatically different detection windows. According to peer-reviewed research and SAMHSA technical guidelines:

Oral fluid detection windows

According to a 2020 review cited in peer-reviewed literature, oral fluid testing detects THC immediately after smoking and remains positive for roughly 24 to 72 hours after use. SAMHSA guidelines for oral fluid testing in federally regulated workplaces specify delta-9 THC as the target analyte, with an initial screening cutoff of 4 ng/mL and a confirmatory cutoff of 2 ng/mL. The relatively short detection window is a feature, not a limitation — it aligns reasonably well with when impairment actually occurs, which is what makes oral fluid attractive for impairment-focused workplace screening.

Urine detection windows

Under the standard 50 ng/mL urine cutoff used in U.S. workplace testing, an occasional or one-time user is unlikely to test positive beyond 3 to 4 days after last use. A chronic or daily user can test positive for 30 days or longer — and in some cases of very heavy long-term use, beyond 90 days. The substance being detected is THC-COOH, the inactive metabolite, which has no impairing effect at any concentration. Under the more sensitive 20 ng/mL cutoff used by some labs, the maximum detection times extend to roughly 7 days for occasional users and 21 days for chronic users.

Hair and blood detection windows

Hair testing detects THC-COOH embedded in the hair shaft and provides the longest detection window of any standard method — up to 90 days. It cannot distinguish between recent and past use within that window. Blood testing detects active delta-9 THC and provides the most direct evidence of recent use, but it is invasive, more expensive, and less practical for routine employer screening than urine or oral fluid.

What does marijuana impairment actually look like?

For employers, the question that matters most is not did the worker use cannabis at some point, but is the worker impaired right now. The science on what cannabis impairment looks like is well-established.

The acute effects

According to NIDA, the CDC's National Institute for Occupational Safety and Health (NIOSH), and peer-reviewed neurocognitive research, acute THC impairment dose-dependently disrupts:

• Attention and concentration — difficulty staying focused on a task or shifting between tasks
• Memory, especially short-term memory — difficulty remembering recent instructions or recent events
• Reaction time — slower response to unexpected events or stimuli
• Motor coordination and manual dexterity — clumsy or imprecise physical movements
• Balance and posture — unsteady movement or impaired ability to maintain stable position
• Spatial perception and depth perception — distorted sense of distance, speed, and physical environment
• Judgment and decision-making — impaired risk assessment and slower complex problem-solving
• Time perception — distorted sense of how much time has passed

NIOSH research specifically notes that THC affects "the body's movements, balance, coordination, memory, and judgment" and "can slow reaction times and reduce the ability to make decisions." The National Safety Council has stated that "there is no level of cannabis use that is safe for safety-sensitive work."

Why impairment matters for safety-sensitive roles

The cluster of impairments THC produces — slowed reaction time, reduced motor coordination, distorted perception, impaired judgment, attention deficits — is the exact cluster that creates risk in safety-sensitive workplaces:

• Commercial driving and fleet operations
• Construction and heavy equipment operation
• Manufacturing and industrial work
• Warehousing and forklift operations
• Field service and utility work
• Working at heights or in confined spaces
• Patient care environments
• Any role where rapid hazard recognition matters

This is the foundation of OSHA's general duty clause as it relates to impairment: employers have an obligation to provide a workplace free from recognized hazards, and impairment is a recognized hazard regardless of the legal status of the substance causing it.

The mismatch: duration of impairment vs. duration of detection

This is the most important practical fact for employers, and the one that has shaped recent state laws around marijuana testing.

According to peer-reviewed research, acute psychoactive effects from inhaled cannabis typically last 2 to 4 hours, though residual effects on cognition and coordination can persist longer, particularly with higher doses. With edibles, peak effects occur later but the impairment window can extend to 6 to 8 hours or more.

Compare that to detection windows:

• Inhaled cannabis impairment window: 2 to 4 hours
• Inhaled cannabis urine detection (chronic user): Up to 30+ days
• Inhaled cannabis oral fluid detection: 24 to 72 hours

A chronic cannabis user can test positive on a urine test for 30 days or longer after their last use, despite having no measurable impairment for the vast majority of that time. This mismatch — between when a person is actually impaired (hours) and when they will test positive on a urine drug test (days to weeks) — is the central scientific challenge in workplace marijuana testing.

This mismatch is also why testing methods that target the active compound rather than the inactive metabolite are increasingly favored for impairment-focused screening. Oral fluid testing, in particular, has become the practical method for employers who need to identify recent cannabis use that is more likely to indicate current impairment, rather than past use that occurred days or weeks before the test.

What this means for employer drug screening programs

For employers building or updating a workplace drug testing program, understanding detection windows informs every program design decision:

• Choosing a testing matrix — urine, oral fluid, hair, or blood. Each detects a different compound over a different time window, and each answers a different question.
• Setting program goals — is the goal to identify any past use, or to identify recent use likely to indicate current impairment? The two goals point to different testing methods.
• Building a defensible reasonable-suspicion protocol — supervisors trained to document the actual signs of impairment described above can pair documentation with a compliant test for a much stronger position than a test result alone.
• Designing post-accident testing — an oral fluid test taken shortly after an incident is more probative of impairment at the time of the accident than a urine test that may reflect use from days earlier.

Testing methods, cutoff levels, panel design, and state law variability are covered in detail in the supporting articles in this series.

Final takeaway

THC clears the body in stages. The active psychoactive compound — delta-9 THC — is detectable in blood and oral fluid for hours to a few days after use, in line with when impairment actually occurs. The inactive metabolite — THC-COOH — is detectable in urine and hair for days to weeks or longer, well after any impairing effects have ended. This mismatch between duration of impairment (typically 2 to 8 hours) and duration of detection (up to 30+ days for chronic users in urine) is the single most important fact for employers building a workplace marijuana testing program. The right testing method depends on what question the program is actually trying to answer — past use, or current impairment.

Sourcing rapid tests for your workplace screening program?

At My BIO TESTS®, we supply rapid, CLIA-Waived FDA 510(k)–cleared drug screening tests, plus Employer & Insurance Use Only and Forensic Use Only options for employer programs. We focus on helping safety-sensitive and multi-location organizations standardize fast, reliable onsite screening workflows with trusted product supply.

Choosing between urine and oral fluid testing for your THC program?

→ Compare rapid urine and oral fluid drug screens for employers

Or call 737-333-5566 | email info@mybiotests.com

Sources

• National Institute on Drug Abuse, Cannabis (Marijuana) Research Report
• CDC / NIOSH, "Cannabis and Work: Implications, Impairment, and the Need for Further Research" (NIOSH Science Bulletin)
• CDC / NIOSH, "Marijuana and Driving: How to Keep Your Fleet's Drivers Safe"
• National Safety Council, "Cannabis and Safety: It's Complicated" position statement
• National Institutes of Health / PMC, "Interpretation of Workplace Tests for Cannabinoids"
• National Institutes of Health / PMC, "A Clinical Framework for Assessing Cannabis-Related Impairment Risk"
• National Institutes of Health / PMC, "Affinity Assays for Cannabinoids Detection: Are They Amenable to On-Site Screening?"
• National Institutes of Health / PMC, "Mechanisms of Action and Pharmacokinetics of Cannabis"
• National Institutes of Health / PMC, "Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis"
• SAMHSA, Mandatory Guidelines for Federal Workplace Drug Testing Programs — Urine and Oral Fluid (current edition)

---

Disclosure: My BIO TESTS® sells rapid urine and oral fluid drug screening tests in three regulatory categories: CLIA-Waived FDA 510(k)–cleared, Employer & Insurance Use Only, and Forensic Use Only. Selection of the appropriate category depends on your testing program and use case. Positive results from any rapid screening test are presumptive and should be confirmed by an HHS-certified laboratory and reviewed by a qualified Medical Review Officer (MRO). This content is educational and is not medical, legal, or scientific advice for any specific testing program. Consult qualified professional counsel before making policy or testing decisions for your workforce.

Last updated: May 2026